Latest News

  • Alkermes Announces New Drug Candidate, ALKS 7119, for Treatment of Alzheimer’s Agitation, Depression and Other CNS Diseases Read More
  • Alkermes’ Corporate Presentation to be Webcast at the Cowen and Company 35th Annual Health Care Conference Read More
  • Alkermes plc Reports Financial Results for the Year Ended Dec. 31, 2014 and Provides Financial Expectations for 2015 Read More

Investors

Learn More

Working at Alkermes

Join Our Team